Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Bipolar Disorder Drugs and Treatment Market

Bipolar Disorder Drugs and Treatment Market Share

Report ID: GMI5795
Published Date: May 2023
Report Format: PDF

Download Free Sample

Bipolar Disorder Drugs & Treatment Market Share

Some of the major market players operating in the bipolar disorder drugs and treatment market are

GlaxoSmithKline (GSK)
Pfizer Inc.
Eli Lily
AbbVie Inc.
Otsuka Holdings Co.Ltd.
AstraZeneca
Novartis AG
Janssen Pharmaceuticals

These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Bipolar disorder drugs and treatment industry size was USD 5.2 billion in 2022 and will reach USD 7.5 billion by 2032 due to the surging government efforts for raising awareness of bipolar diseases.

Bipolar disorder drugs and treatment industry share from the anti-psychotic drugs segment recorded USD 2.1 billion in 2022 owing to the growing need to control psychotic symptoms such as delusions, hallucinations, and mania in bipolar disorder.

The oral route of administration held 59.2% of the bipolar disorder drugs and treatment industry share in 2022 due to their easy consumption.

U.S. bipolar disorder drugs and treatment industry size reached USD 1.9 billion in 2022 due to the increasing prevalence of bipolar disorders in the region.